Health Highlights: Dec. 14, 2022
New drug might be an advance against eczema. Rocatinlimab is a monoclonal antibody that researchers found prevented the recurrence of the symptoms of the skin condition for up to 20 weeks after treatment was stopped. Read moreMove to electric cars wil…
Learn MoreIs Good Sleep Tougher to Find in Winter? Morning Light May Help
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — If you want to get some good sleep at night, be sure to get outside for a bit during the day, even if it’s cloudy. That’s the advice of researchers at the University of Washington in Seattle, where overcast…
Learn MoreLoss of Bees Could Harm Health of Millions of People
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — Bees, in their role as master pollinators, increase crop yields, leading to more production of healthy fruits, vegetables and nuts. But new research claims that the challenges these important insects face f…
Learn MorePatients’ Genes Raise Odds for Rare Brain Infection When Using Certain Meds
WEDNESDAY, Dec. 14, 2022 (HealthDay News) — For some people, dozens of U.S.-approved drugs can lead to a rare but often fatal brain infection. Researchers have now confirmed a strong link between four genetic mutations and this illness, called progre…
Learn MoreSeverity of Acute COVID-19 Tied to Frequency of Long COVID Diagnosis
TUESDAY, Dec. 13, 2022 (HealthDay News) — The frequency of occurrence of long COVID substantially differs based on severity of the acute infection, according to a study published online Dec. 7 in the Journal of Internal Medicine.Pontus Hedberg, M.D.,…
Learn MorePoison Center Calls for Youth Up for Marijuana
TUESDAY, Dec. 13, 2022 (HealthDay News) — U.S. poison centers reported greater than 330,000 misuse and abuse exposure cases and 450 deaths over 20 years for school-aged children and adolescents, according to a study published online Dec. 5 in Clinica…
Learn MoreFemales, Some Minorities Underrepresented in COVID-19 Clinical Trials
TUESDAY, Dec. 13, 2022 (HealthDay News) — Females are underrepresented in COVID-19 treatment trials, while Asian and Black individuals are underrepresented in COVID-19 prevention trials, according to a review published online Dec. 5 in JAMA Internal …
Learn MoreChildren Report Changing Symptoms in Year Following COVID-19
TUESDAY, Dec. 13, 2022 (HealthDay News) — In the year following severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection, self-reported symptoms evolve in children and youth, according to a study published online Dec. 5 in The Lancet Re…
Learn MoreModerna, Merck Report on Promising Melanoma Vaccine
TUESDAY, Dec. 13, 2022 (HealthDay News) — Two pharmaceutical companies said Tuesday that they have made notable progress with a vaccine that could prevent melanoma.Moderna, well known for its work on the COVID-19 vaccine, and Merck, which makes the c…
Learn MoreCalifornia’s Flavored Tobacco Ban Will Not Be Blocked by Supreme Court
TUESDAY, Dec. 13, 2022 (HealthDay News) — An attempt to block California’s flavored tobacco ban was stopped Monday when the Supreme Court declined to hear the case. That now means the ban will go into effect on Dec. 21.The ban includes everything fro…
Learn More